{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T22:06:34Z","timestamp":1779055594531,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,17]]},"DOI":"10.7759\/cureus.109043","type":"journal-article","created":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T21:52:49Z","timestamp":1779054769000},"source":"Crossref","is-referenced-by-count":0,"title":["Sacral Neuromodulation Outcomes for Managing Urinary Incontinence in Patients With Overactive and Neurogenic Bladder"],"prefix":"10.7759","author":[{"given":"Chelsae","family":"Nugent","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Carre\u00f1o Galeano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kellen","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00192-009-0976-9","article-title":"An International Urogynecological Association (IUGA)\/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction","volume":"21","author":"Haylen BT","year":"2010","unstructured":"Haylen BT, de Ridder D, Freeman RM, et al.. An International Urogynecological Association (IUGA)\/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J. 2010, 21:5-26. 10.1007\/s00192-009-0976-9","journal-title":"Int Urogynecol J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000003985","article-title":"The AUA\/SUFU guideline on the diagnosis and treatment of idiopathic overactive bladder","volume":"212","author":"Cameron AP","year":"2024","unstructured":"Cameron AP, Chung DE, Dielubanza EJ, et al.. The AUA\/SUFU guideline on the diagnosis and treatment of idiopathic overactive bladder. J Urol. 2024, 212:11-20. 10.1097\/JU.0000000000003985","journal-title":"J Urol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00192-024-06029-2","article-title":"Global prevalence of overactive bladder: a systematic review and meta-analysis","volume":"36","author":"Zhang L","year":"2025","unstructured":"Zhang L, Cai N, Mo L, Tian X, Liu H, Yu B. Global prevalence of overactive bladder: a systematic review and meta-analysis. Int Urogynecol J. 2025, 36:1547-66. 10.1007\/s00192-024-06029-2","journal-title":"Int Urogynecol J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-002-0301-4","article-title":"Prevalence and burden of overactive bladder in the United States","volume":"20","author":"Stewart WF","year":"2003","unstructured":"Stewart WF, Van Rooyen JB, Cundiff GW, et al.. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003, 20:327-36. 10.1007\/s00345-002-0301-4","journal-title":"World J Urol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5213\/inj.2346014.007","article-title":"Effectiveness of fluid and caffeine modifications on symptoms in adults with overactive bladder: a systematic review","volume":"27","author":"Park J","year":"2023","unstructured":"Park J, Lee H, Kim Y, Norton C, Woodward S, Lee S. Effectiveness of fluid and caffeine modifications on symptoms in adults with overactive bladder: a systematic review. Int Neurourol J. 2023, 27:23-35. 10.5213\/inj.2346014.007","journal-title":"Int Neurourol J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-63448-3","article-title":"The association between overactive bladder and systemic immunity-inflammation index: a cross-sectional study of NHANES 2005 to 2018","volume":"14","author":"Wei B","year":"2024","unstructured":"Wei B, Zhao Y, Lin P, et al.. The association between overactive bladder and systemic immunity-inflammation index: a cross-sectional study of NHANES 2005 to 2018. Sci Rep. 2024, 14:12579. 10.1038\/s41598-024-63448-3","journal-title":"Sci Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/nau.24936","article-title":"Barriers and facilitators to overactive bladder therapy adherence","volume":"41","author":"Enemchukwu EA","year":"2022","unstructured":"Enemchukwu EA, Subak LL, Markland A. Barriers and facilitators to overactive bladder therapy adherence. Neurourol Urodyn. 2022, 41:1983-92. 10.1002\/nau.24936","journal-title":"Neurourol Urodyn"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1530\/EOR-24-0087","article-title":"Neurogenic bladder pathophysiology, assessment and management after lumbar diseases","volume":"10","author":"Hao J","year":"2025","unstructured":"Hao J, Jiang J, Han Q, Wang K, Sun Y, Wang H. Neurogenic bladder pathophysiology, assessment and management after lumbar diseases. EFORT Open Rev. 2025, 10:156-65. 10.1530\/EOR-24-0087","journal-title":"EFORT Open Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000002235","article-title":"The AUA\/SUFU guideline on adult neurogenic lower urinary tract dysfunction: diagnosis and evaluation","volume":"206","author":"Ginsberg DA","year":"2021","unstructured":"Ginsberg DA, Boone TB, Cameron AP, et al.. The AUA\/SUFU guideline on adult neurogenic lower urinary tract dysfunction: diagnosis and evaluation. J Urol. 2021, 206:1097-105. 10.1097\/JU.0000000000002235","journal-title":"J Urol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-018-2301-z","article-title":"Epidemiology and pathophysiology of neurogenic bladder after spinal cord injury","volume":"36","author":"Hamid R","year":"2018","unstructured":"Hamid R, Averbeck MA, Chiang H, et al.. Epidemiology and pathophysiology of neurogenic bladder after spinal cord injury. World J Urol. 2018, 36:1517-27. 10.1007\/s00345-018-2301-z","journal-title":"World J Urol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-023-03884-8","article-title":"Management of spinal cord injury patients with neurogenic lower urinary tract dysfunction using minimally invasive and surgical therapies in Taiwan","volume":"56","author":"Chen SF","year":"2024","unstructured":"Chen SF, Kuo HC. Management of spinal cord injury patients with neurogenic lower urinary tract dysfunction using minimally invasive and surgical therapies in Taiwan. Int Urol Nephrol. 2024, 56:1205-16. 10.1007\/s11255-023-03884-8","journal-title":"Int Urol Nephrol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12052021","article-title":"Conservative bladder management and medical treatment in chronic spinal cord injury patients","volume":"12","author":"Ong HL","year":"2023","unstructured":"Ong HL, Chiang IN, Hsu LN, et al.. Conservative bladder management and medical treatment in chronic spinal cord injury patients. J Clin Med. 2023, 12:2021. 10.3390\/jcm12052021","journal-title":"J Clin Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/nau.24172","article-title":"Reasons for cessation of clean intermittent catheterization after spinal cord injury: results from the Neurogenic Bladder Research Group spinal cord injury registry","volume":"39","author":"Patel DP","year":"2020","unstructured":"Patel DP, Herrick JS, Stoffel JT, et al.. Reasons for cessation of clean intermittent catheterization after spinal cord injury: results from the Neurogenic Bladder Research Group spinal cord injury registry. Neurourol Urodyn. 2020, 39:211-9. 10.1002\/nau.24172","journal-title":"Neurourol Urodyn"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cont.2024.101328","article-title":"The history of neuromodulation for lower urinary tract dysfunction: an overview","volume":"11","author":"Van Kerrebroeck P","year":"2024","unstructured":"Van Kerrebroeck P, Van den Hombergh U . The history of neuromodulation for lower urinary tract dysfunction: an overview. Continence. 2024, 11:101328. 10.1016\/j.cont.2024.101328","journal-title":"Continence"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s11934-025-01280-6","article-title":"Off-label but on-target: sacral neuromodulation for neurogenic bladder dysfunction","volume":"26","author":"Vogel K","year":"2025","unstructured":"Vogel K, Nakib N. Off-label but on-target: sacral neuromodulation for neurogenic bladder dysfunction. Curr Urol Rep. 2025, 26:52. 10.1007\/s11934-025-01280-6","journal-title":"Curr Urol Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s11884-016-0383-2","article-title":"Worldwide utilization patterns of sacral neuromodulation for neurogenic lower urinary tract dysfunction","volume":"11","author":"Averbeck M","year":"2016","unstructured":"Averbeck M, Gomes C. Worldwide utilization patterns of sacral neuromodulation for neurogenic lower urinary tract dysfunction. Curr Bladder Dysfunct Rep. 2016, 11:356-64. 10.1007\/s11884-016-0383-2","journal-title":"Curr Bladder Dysfunct Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cont.2024.101323","article-title":"Sacral neuromodulation for non classical indications","volume":"11","author":"Kopkin R","year":"2024","unstructured":"Kopkin R, Gallo K, Comiter C. Sacral neuromodulation for non classical indications. Continence. 2024, 11:101323. 10.1016\/j.cont.2024.101323","journal-title":"Continence"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.5213\/inj.2448144.122","article-title":"Implantable neuromodulation for neurogenic lower urinary tract dysfunction: a single-institution retrospective study","volume":"28","author":"Buford K","year":"2024","unstructured":"Buford K, Eisner H, Vollstedt A, et al.. Implantable neuromodulation for neurogenic lower urinary tract dysfunction: a single-institution retrospective study. Int Neurourol J. 2024, 28:278-84. 10.5213\/inj.2448144.122","journal-title":"Int Neurourol J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/nau.24954","article-title":"Neuromodulation for lower urinary tract symptoms in special populations","volume":"41","author":"Wang CN","year":"2022","unstructured":"Wang CN, Chung DE. Neuromodulation for lower urinary tract symptoms in special populations. Neurourol Urodyn. 2022, 41:1948-57. 10.1002\/nau.24954","journal-title":"Neurourol Urodyn"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-018-0383-y","article-title":"Protocol for a randomized clinical trial investigating early sacral nerve stimulation as an adjunct to standard neurogenic bladder management following acute spinal cord injury","volume":"18","author":"Redshaw JD","year":"2018","unstructured":"Redshaw JD, Lenherr SM, Elliott SP, Stoffel JT, Rosenbluth JP, Presson AP, Myers JB. Protocol for a randomized clinical trial investigating early sacral nerve stimulation as an adjunct to standard neurogenic bladder management following acute spinal cord injury. BMC Urol. 2018, 18:72. 10.1186\/s12894-018-0383-y","journal-title":"BMC Urol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/477345-sacral-neuromodulation-outcomes-for-managing-urinary-incontinence-in-patients-with-overactive-and-neurogenic-bladder","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T21:52:50Z","timestamp":1779054770000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/477345-sacral-neuromodulation-outcomes-for-managing-urinary-incontinence-in-patients-with-overactive-and-neurogenic-bladder"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,17]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.109043","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,17]]}}}